Health Topics — Women's Health
Peri-menopause and the Body That Changed
For the woman who doesn't recognize her own body anymore — what peri-menopause actually does to the biology of stress, sleep, mood, and pain, and what the research has begun to examine.
Something changed. Not dramatically, not all at once — but it changed. The sleep you could count on started failing. The mood that used to be predictable began arriving sideways. Things that were manageable feel heavier now. Your body is behaving like a stranger's, and the explanations you've been given — "it's just hormones," "it's part of aging" — don't quite account for the weight of what's actually happening.
Peri-menopause is one of the most significant biological transitions in a woman's life, and one of the least honestly discussed. This is an attempt to do that more honestly.
Peri-menopause is not the same as menopause. It is the years — often many years — of hormonal transition that precede it. During this period, estrogen does not simply decline. It fluctuates erratically. Some months it surges higher than it did in your thirties. Others it drops sharply. Progesterone, meanwhile, begins a more sustained decline. The result is a hormonal landscape that is genuinely unpredictable in a way that the steady rhythm of earlier reproductive years was not.
This erratic fluctuation is why peri-menopause can feel so disorienting. The hot flashes that appear before your periods have changed significantly. The sleep disruption that seems unrelated to anything external. The anxiety that arrives without a clear cause. The mood that tracks a pattern you can't quite identify. These are not disconnected symptoms. They are the body's response to hormonal instability — and one of the systems most directly affected by that instability is the endocannabinoid system.
Why the body feels different — not just older
Estrogen and the endocannabinoid system are directly connected. When estrogen is present in adequate amounts, it supports the availability of anandamide — one of the body's own endocannabinoids, involved in regulating mood, pain sensitivity, sleep quality, and the ability to resolve stress. Estrogen does this in two ways simultaneously: it promotes the production of anandamide and slows the enzyme that breaks it down. This double effect means that estrogen levels and endocannabinoid tone tend to track together.
When estrogen fluctuates erratically — as it does throughout peri-menopause — so does endocannabinoid tone. The regulatory capacity that the endocannabinoid system provides for mood, stress response, sleep, and pain modulation becomes less stable. Not absent — less stable. This is why the symptoms of peri-menopause aren't simply "low estrogen" symptoms. They are the symptoms of a regulatory system that is no longer operating on a reliable rhythm.
It is also why stress hits differently during this transition. Chronic stress was already a disruption to hormonal health before peri-menopause — cortisol suppresses the hormonal signaling that supports healthy cycles. During peri-menopause, when estrogen fluctuation is already destabilizing the endocannabinoid system's regulatory function, sustained stress load compounds the instability. The body that used to absorb stress and recover is the same body — but the biology supporting that recovery has become less consistent.
What the research on CBG and CBD has examined
CBD interacts with the enzyme that breaks down anandamide — slowing its degradation and supporting higher anandamide availability. During a phase when estrogen fluctuation is making anandamide levels less predictable, this mechanism is directly relevant, even though no clinical trial has yet tested CBD specifically in a peri-menopausal population.
CBG's research is relevant through the stress pathway. The first controlled human trial of CBG — published in 2024 — found statistically significant reductions in self-reported anxiety and stress compared to placebo in healthy adults. Because chronic stress is one of the primary disruptors of the hormonal stability that peri-menopause already has in short supply, a preparation that supports the body's stress-regulatory capacity may have relevance here even in the absence of peri-menopause-specific research.
A clinical trial specifically examining CBG in a peri-menopausal or post-menopausal population is currently underway at Washington State University. When that research publishes, the mechanism articles in this pillar will be updated to incorporate its findings. Until then, the research on CBG in the stress domain and CBD in the anandamide-supporting domain represents the honest evidence base.
On what we can and cannot say
No human trial has tested CBG or CBD specifically for peri-menopausal symptoms. The research described here is mechanistic — it documents biological relationships between cannabinoids and systems that are relevant to peri-menopause, not clinical outcomes in a peri-menopausal population.
We present this research in that proportion. The mechanisms are real and documented. The clinical evidence for this specific population is still developing.
What this means in practice
We can't tell you that a CBG or CBD preparation will resolve peri-menopausal symptoms. What we can offer is the honest biological framework — so that if you are considering a whole-plant cannabinoid preparation during this transition, you have a real context for thinking about it rather than marketing language.
The preparations we make are whole-plant — the full botanical range of the hemp plant preserved through traditional alcohol maceration and slow-heat oil infusion. We grow what we prepare. If you decide to try one during peri-menopause, consistency over weeks rather than single-dose expectations is aligned with how the endocannabinoid system's regulatory function works.
Future articles in this pillar will examine specific aspects of this transition in more detail — the weight and metabolic changes that often accompany peri-menopause, the relationship between estrogen fluctuation and sleep specifically, and the updated evidence from the Cuttler WSU trial when it publishes. The research section has the fuller mechanism picture now if you want to go deeper.
The body that feels like it has changed isn't imagining it. Peri-menopause is a real biological transition with documented effects on the endocannabinoid system — the same system that regulates stress, sleep, mood, and pain. The research on CBG and CBD in this context is still developing. What exists is worth understanding honestly. You deserve accurate information about what is happening in your body, and this archive is built to provide it.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.